|
1
|
Galli R, Binda E, Orfanelli U, Cipelletti
B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi
A: Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lathia JD, Mack SC, Mulkearns-Hubert EE,
Valentim CL and Rich JN: Cancer stem cells in glioblastoma. Genes
Dev. 29:1203–1217. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q,
Hjelmeland AB, Dewhirst MW, Bigner DD and Rich JN: Glioma stem
cells promote radioresistance by preferential activation of the DNA
damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen J, Li Y, Yu TS, McKay RM, Burns DK,
Kernie SG and Parada LF: A restricted cell population propagates
glioblastoma growth after chemotherapy. Nature. 488:522–526. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Seymour T, Nowak A and Kakulas F:
Targeting aggressive cancer stem cells in glioblastoma. Front
Oncol. 5:1592015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu S, Yin F, Zhang J, Wicha MS, Chang AE,
Fan W, Chen L, Fan M and Li Q: Regulatory roles of miRNA in the
human neural stem cell transformation to glioma stem cells. J Cell
Biochem. 115:1368–1380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Schiff D, Park D and Abounader R:
MicroRNA-608 and microRNA-34a regulate chordoma malignancy by
targeting EGFR, Bcl-xL and MET. PLoS One. 9:e915462014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mittelbronn M, Platten M, Zeiner P,
Dombrowski Y, Frank B, Zachskorn C, Harter PN, Weller M and
Wischhusen J: Macrophage migration inhibitory factor (MIF)
expression in human malignant gliomas contributes to immune escape
and tumour progression. Acta Neuropathol. 122:353–365. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang XB, Tian XY, Li Y, Li B and Li Z:
Elevated expression of macrophage migration inhibitory factor
correlates with tumor recurrence and poor prognosis of patients
with gliomas. J Neurooncol. 106:43–51. 2012. View Article : Google Scholar
|
|
10
|
Ströbele S, Schneider M, Schneele L,
Siegelin MD, Nonnenmacher L, Zhou S, Karpel-Massler G, Westhoff MA,
Halatsch ME and Debatin KM: A potential role for the inhibition of
PI3K signaling in glioblastoma therapy. PLoS One. 10:e01316702015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J and Lin A: Role of JNK activation in
apoptosis: A double-edged sword. Cell Res. 15:36–42. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuda K, Sato A, Okada M, Shibuya K,
Seino S, Suzuki K, Watanabe E, Narita Y, Shibui S, Kayama T, et al:
Targeting JNK for therapeutic depletion of stem-like glioblastoma
cells. Sci Rep. 2:5162012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alapati K, Kesanakurti D, Rao JS and
Dasari VR: uPAR and cathepsin B-mediated compartmentalization of
JNK regulates the migration of glioma-initiating cells. Stem Cell
Res (Amst). 12:716–729. 2014. View Article : Google Scholar
|
|
14
|
Lue H, Dewor M, Leng L, Bucala R and
Bernhagen J: Activation of the JNK signalling pathway by macrophage
migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.
Cell Signal. 23:135–144. 2011. View Article : Google Scholar
|
|
15
|
Yeh TM, Liu SH, Lin KC, Kuo C, Kuo SY,
Huang TY, Yen YR, Wen RK, Chen LC and Fu TF: Dengue virus enhances
thrombomodulin and ICAM-1 expression through the macrophage
migration inhibitory factor induction of the MAPK and PI3K
signaling pathways. PLoS One. 8:e550182013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang FL, Wang P, Liu YH, Liu LB, Liu XB,
Li Z and Xue YX: Topoisomerase I inhibitors, shikonin and
topotecan, inhibit growth and induce apoptosis of glioma cells and
glioma stem cells. PLoS One. 8:e818152013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao Y, Xue Y, Ma J, Shang C, Wang P, Liu
L, Liu W, Li Z, Qu S, Li Z, et al: miR-330-mediated regulation of
SH3GL2 expression enhances malignant behaviors of glioblastoma stem
cells by activating ERK and PI3K/AKT signaling pathways. PLoS One.
9:e950602014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Khasraw M and Lassman AB: Advances in the
treatment of malignant gliomas. Curr Oncol Rep. 12:26–33. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Clevers H: The cancer stem cell: Premises,
promises and challenges. Nat Med. 17:313–319. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Malik B and Nie D: Cancer stem cells and
resistance to chemo and radio therapy. Front Biosci (Elite Ed).
4:2142–2149. 2012. View
Article : Google Scholar
|
|
23
|
Lin J, Horikawa Y, Tamboli P, Clague J,
Wood CG and Wu X: Genetic variations in microRNA-related genes are
associated with survival and recurrence in patients with renal cell
carcinoma. Carcinogenesis. 31:1805–1812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang AJ, Yu KD, Li J, Fan L and Shao ZM:
Polymorphism rs4919510:C>G in mature sequence of human
microRNA-608 contributes to the risk of HER2-positive breast cancer
but not other subtypes. PLoS One. 7:e352522012. View Article : Google Scholar :
|
|
25
|
Ryan BM, McClary AC, Valeri N, Robinson D,
Paone A, Bowman ED, Robles AI, Croce C and Harris CC: rs4919510 in
hsa-mir-608 is associated with outcome but not risk of colorectal
cancer. PLoS One. 7:e363062012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qiu F, Yang L, Zhang L, Yang X, Yang R,
Fang W, Wu D, Chen J, Xie C, Huang D, et al: Polymorphism in mature
microRNA-608 sequence is associated with an increased risk of
nasopharyngeal carcinoma. Gene. 565:180–186. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Baron N, Deuster O, Noelker C, Stüer C,
Strik H, Schaller C, Dodel R, Meyer B and Bacher M: Role of
macrophage migration inhibitory factor in primary glioblastoma
multiforme cells. J Neurosci Res. 89:711–717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi L, Fei X, Wang Z and You Y: PI3K
inhibitor combined with miR-125b inhibitor sensitize TMZ-induced
anti-glioma stem cancer effects through inactivation of
Wnt/β-catenin signaling pathway. In Vitro Cell Dev Biol Anim.
51:1047–1055. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu J, Liu L, Xue Y, Meng F, Li S, Wang P
and Liu Y: Anti-neoplastic activity of low-dose
endothelial-monocyte activating polypeptide-II results from
defective autophagy and G2/M arrest mediated by PI3K/Akt/FoxO1 axis
in human glioblastoma stem cells. Biochem Pharmacol. 89:477–489.
2014. View Article : Google Scholar : PubMed/NCBI
|
